← Back to Search

Behavioral Intervention

Pivotal Response Treatment for Autism (PRT-HvC Trial)

N/A
Recruiting
Led By Antonio Y. Hardan, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Boys and girls between 2.0 and 5.11 years
No more than 60 minutes of individual 1:1 speech therapy per week
Must not have
Presence of active medical problem
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline,16 weeks.
Awards & highlights

Summary

This trial is comparing two different types of therapy for children with autism who have language delays. One group will receive therapy at a center, and the other group will receive therapy at home. There is also a control group who will receive usual treatment.

Who is the study for?
This trial is for young children aged 2 to 5.11 years with autism spectrum disorder (ASD) and a significant language delay, who are receiving no more than an hour of speech therapy per week. They must have stable treatment for at least one month prior and be able to participate in testing procedures. Children with severe psychiatric disorders, unstable medical conditions, or those already having extensive ABA therapy are not eligible.
What is being tested?
The study compares two methods of Pivotal Response Treatment over 16 weeks: one delivered in a center (PRT-C) and the other at home (PRT-H), against usual treatments. It aims to see which setting better improves social communication skills in children with ASD.
What are the potential side effects?
Since Pivotal Response Treatment involves behavioral interventions rather than medication, traditional side effects like you'd expect from drugs aren't applicable here. However, there may be variations in how each child responds to the intensity and setting of the therapy.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child is between 2 and 5 years old.
Select...
I receive 60 minutes or less of speech therapy weekly.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a current health issue that needs treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline,16 weeks.
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline,16 weeks. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Change From Baseline in Parent Rated Social Responsiveness Scale, 2nd Edition (SRS-2) Scores
Change From Baseline in Parent Rated Stanford Social Dimension Scale (SSDS) Scores

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Home-Based Pivotal Response Treatment (PRT) Intervention (PRT-H)Experimental Treatment1 Intervention
A 16-week home-based PRT intervention (PRT-H) consisting of 12 hours per week including 1 hour of parent training. This intervention targets social communication deficits.
Group II: Center-Based Pivotal Response Treatment (PRT) Intervention (PRT-C)Experimental Treatment1 Intervention
A 16-week center-based PRT intervention (PRT-C) consisting of 12 hours per week including 1 hour of parent training. This intervention targets social communication deficits.
Group III: Treatment As Usual (TAU)Active Control1 Intervention
This is a control group that consists of children who are receiving treatment as usual (TAU) for a 16-week period. These families will be invited to participate in PRT after completing the 16-week TAU phase.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,448 Previous Clinical Trials
17,492,274 Total Patients Enrolled
Anonymous DonorUNKNOWN
Antonio Y. Hardan, MDPrincipal InvestigatorStanford University
9 Previous Clinical Trials
361 Total Patients Enrolled

Media Library

Center-Based Pivotal Response Treatment (PRT) Intervention (PRT-C) (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04899544 — N/A
~60 spots leftby Sep 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top